‘The second Amosartan Naxozol, lead Hanmi growth for three years’
(Digital BOSA)
‘Patient charge will reduce by 33% and surpass Celebrex reputation’
“Naxozol is a product that will drive the growth of Hanmi for the next three years. You can regard it as the second Amosartan,” said Dae-Sung Kyung, product manager of ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
